Brian M. Slomovitz - Division of Gynecologic Oncology, Mount Sinai Medical Center

Vicky Makker, Debra L. Richardson, Hye Sook Chon, David Scott Miller, Morten Mau-Sorensen,David Cibula,Flora Zagouri, Alejandro Perez Fidalgo,Brian M. Slomovitz,Robert L. Coleman, Pratheek Kalyanapu, Rong Fan, Girish Gudi,Ignace Vergote

JOURNAL OF CLINICAL ONCOLOGYno. 16 (2024)

Cited0Views0Bibtex

Tisotumab Vedotin As Second- or Third-Line Therapy for Recurrent Cervical Cancer

Ignace Vergote,Antonio Gonzalez-Martin,Keiichi Fujiwara,Elsa Kalbacher, Andrea Bagameri,Sharad Ghamande,Jung-Yun Lee,Susana Banerjee,Fernando Cotait Maluf,Domenica Lorusso,Kan Yonemori,Els Van Nieuwenhuysen,Luis Manso,Linn Woelber,Anneke Westermann,Allan Covens,Kosei Hasegawa,Byoung-Gie Kim, Miriam Raimondo,Maria Bjurberg,Felipe Melo Cruz,Antoine Angelergues,David Cibula,Lisa Barraclough,Ana Oaknin,Christine Gennigens, Leo Nicacio, Melinda Siew Leng Teng, Elizabeth Whalley,Ibrahima Soumaoro,Brian M. Slomovitz

NEW ENGLAND JOURNAL OF MEDICINEno. 1 (2024): 44-55

Cited0Views0WOSBibtex

Post Hoc Analysis of Progression-Free Survival (PFS) and Overall Survival (OS) by Mechanism of Mismatch Repair (MMR) Protein Loss in Patients with Endometrial Cancer (EC) Treated with Dostarlimab Plus Chemotherapy in the RUBY Trial

Mansoor Raza Mirza,Sudarshan Sharma,Henrik Roed,Lisa M. Landrum,Lucy Gilbert,Michael A. Gold,Zoltan Novak,Mitchell Edelson,Mihai Meirovitz,John Paul Diaz, Greet Huygh,Joseph Buscema,Bhavana Pothuri, Helen Dinkelspiel Eshed,Robert L. Coleman,Brian M. Slomovitz, Rumen Kostadinov,Shadi Stevens,Graziana Ronzino,Matthew A. Powell

JOURNAL OF CLINICAL ONCOLOGYno. 16 (2024)

Cited0Views0Bibtex

Efficacy and Safety of Tisotumab Vedotin Versus Investigator's Choice of Chemotherapy in Second-Line or Third-Line Recurrent or Metastatic Cervical Cancer (innovatv 301/Engot-Cx12/gog-3057): A Global, Randomized, Open-Label, Phase III Study

Brian Slomovitz,Antonio González-Martín,Keiichi Fujiwara,Elsa Kalbacher, Andrea Bagaméri,Leslie Randall,Jung-Yun Lee, Susana Banerjee, Fernando Maluf,Domenica Lorusso, Kan Yonemori,Els Van Nieuwenhuysen, Luis Manso, Linn Woelber,Anneke Westermann,Allan Covens, Elizabeth Whalley, Yiyi Chen,Ibrahima Soumaoro,Ignace Vergote

Gynecologic Oncology (2024)

Cited0Views0Bibtex

Top Advances of the Year: Uterine Cancer

Britt K Erickson,Brian Slomovitz,Matthew Powell,Ramez N Eskander

Cancer（2024）

Cited0Views0WOSBibtex

GOG 3088: A Randomized Phase II Study of Letrozole Versus Observation in Patients with Newly Diagnosed Uterine Leiomyosarcoma

Bradley Corr, Michael Sill, Jennifer Klein,Thomas J. Herzog,Robert L. Coleman,Brian M. Slomovitz

JOURNAL OF CLINICAL ONCOLOGYno. 16 (2024)

Cited0Views0Bibtex

GOG3069: Phase 2 Study of Alpelisib and Fulvestrant for PIK3CA-mutated Estrogen Receptor (Er)-Positive Endometrioid Endometrial Cancers

Stephanie Gaillard, Michael Sill, Jennifer Klein,Thomas Reid, Michael Callahan, Julia Fehniger, Janelle Sobecki, Michael A. Gold,Thomas J. Herzog,Brian M. Slomovitz,Ursula A. Matulonis

JOURNAL OF CLINICAL ONCOLOGYno. 16 (2024)

Cited0Views0Bibtex

Author Statistics

Co-Author

Co-Institution

D-Core

合作者
学生
导师

No result temporarily, you can search similar Scholar with the same research interest

Data Disclaimer

The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn